Your browser doesn't support javascript.
loading
Pneumonia Severity and Phase Linked to Virus-Specific T Cell Responses with Distinct Immune Checkpoints during pH1N1 Infection.
Li, Hui; Zhao, Min; Zhang, Hangjie; Quan, Chuansong; Zhang, Dannie; Liu, Yingmei; Liu, Meng; Xue, Chunxue; Tan, Shuguang; Guo, Yaxin; Zhao, Yingze; Wu, Guizhen; Gao, George F; Cao, Bin; Liu, William J.
Afiliação
  • Li H; Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, China-Japan Friendship Hospital, Beijing, China.
  • Zhao M; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Zhang H; University of Chinese Academy of Sciences, Beijing, China.
  • Quan C; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang D; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Liu Y; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Liu M; Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, China-Japan Friendship Hospital, Beijing, China.
  • Xue C; Clinical Center for Pulmonary Infections, Capital Medical University, Beijing, China.
  • Tan S; Clinical Center for Pulmonary Infections, Capital Medical University, Beijing, China.
  • Guo Y; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Zhao Y; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wu G; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Gao GF; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Cao B; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China; gaof@im.ac.cn caobin_ben@163.com liujun@ivdc.chinacdc.cn.
  • Liu WJ; University of Chinese Academy of Sciences, Beijing, China.
J Immunol ; 208(9): 2154-2162, 2022 05 01.
Article em En | MEDLINE | ID: mdl-35418471

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Influenza Humana Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Influenza Humana Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China